Insidermedicine in 60 - April 28 2008

Description: From Washington - Taking alendronate, or Fosamax, for osteoporosis may raise the risk of irregular heart beat. In a study where over 700 women with atrial fibrillation were compared to nearly 1000 controls, those who took Fosamax had a 50% higher risk of developing atrial fibrillation. Up to 3% of all new cases of atrial fibrillation may be attributed to alendronate use. From London - Molecular treatments may be close for common retinal conditions like macular degeneration and retinitis ...